These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 19189893)
1. [Colonoscopy, the primary tool for colonic screening]. Péter Z; Tulassay Z Orv Hetil; 2009 Feb; 150(7):299-304. PubMed ID: 19189893 [TBL] [Abstract][Full Text] [Related]
2. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?]. Trevisani L; Cifalà V; Sartori S; Tombesi P; Matarese V; Pezzoli A; Abbasciano V Recenti Prog Med; 2009 Feb; 100(2):68-72. PubMed ID: 19350797 [TBL] [Abstract][Full Text] [Related]
3. Fecal occult blood testing when colonoscopy capacity is limited. Wilschut JA; Habbema JD; van Leerdam ME; Hol L; Lansdorp-Vogelaar I; Kuipers EJ; van Ballegooijen M J Natl Cancer Inst; 2011 Dec; 103(23):1741-51. PubMed ID: 22076285 [TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests. Heresbach D; Chauvin P; Grolier J; Josselin JM Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341 [TBL] [Abstract][Full Text] [Related]
5. Cost savings in mass population screening for colorectal cancer resulting from the early detection and excision of adenomas. Whynes DK; Walker AR; Hardcastle JD Health Econ; 1992 Apr; 1(1):53-60. PubMed ID: 1342630 [TBL] [Abstract][Full Text] [Related]
6. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. Lieberman DA; Weiss DG; N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208 [TBL] [Abstract][Full Text] [Related]
7. Screening for colorectal cancer: the cost to find an advanced adenoma. McGrath JS; Ponich TP; Gregor JC Am J Gastroenterol; 2002 Nov; 97(11):2902-7. PubMed ID: 12425566 [TBL] [Abstract][Full Text] [Related]
8. [Controversial issues in colorectal screening in Hungary: conflict of clinical and public health viewpoints]. Döbrossy L; Kovács A; Budai A; Simon J; Horváth AR; Cornides A; Tulassay Z Orv Hetil; 2011 Jul; 152(31):1223-32. PubMed ID: 21788205 [TBL] [Abstract][Full Text] [Related]
9. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas. Khalid-de Bakker CA; Jonkers DM; Sanduleanu S; de Bruïne AP; Meijer GA; Janssen JB; van Engeland M; Stockbrügger RW; Masclee AA Cancer Prev Res (Phila); 2011 Oct; 4(10):1563-71. PubMed ID: 21750209 [TBL] [Abstract][Full Text] [Related]
10. [Position statement of the College of Surgery of Hungary about screening for colorectal cancer]. Sebészeti Szakmai Kollégium Orv Hetil; 2008 Nov; 149(46):2195-6. PubMed ID: 19004739 [No Abstract] [Full Text] [Related]
11. Effectiveness of the immunochemical fecal test (FIT) for detection of advanced adenomas in colorectal carcinoma screening in an asymptomatic population. Miuţescu B; Sporea I; Popescu A; Bota S; Iovănescu D; Burlea A; Mos L; Palaghia M; Vasilescu A; Miuţescu E Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):302-7. PubMed ID: 24340508 [TBL] [Abstract][Full Text] [Related]
12. [Arguments against implementing a population-based screening programme for colorectal cancer]. Bonneux L Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310 [TBL] [Abstract][Full Text] [Related]
13. [The state of the colorectal screening in Hungary: lessons of the pilot programs]. Döbrôssy L; Kovács A; Budai A; Cornides A; Ottó S; Tulassay Z Orv Hetil; 2007 Sep; 148(38):1787-93. PubMed ID: 17872333 [TBL] [Abstract][Full Text] [Related]
14. Screening for colorectal cancer. Guittet L; Launoy G N Engl J Med; 2010 Jan; 362(1):84-5; author reply 85. PubMed ID: 20054054 [No Abstract] [Full Text] [Related]
15. Is it time to recommend screening for colorectal cancer? Lieberman D; Sleisenger MH Lancet; 1996 Nov; 348(9040):1463-4. PubMed ID: 8942770 [No Abstract] [Full Text] [Related]
16. Colonoscopy requirements of population screening for colorectal cancer in New Zealand. Green T; Richardson A; Parry S N Z Med J; 2012 Jun; 125(1356):85-95. PubMed ID: 22729063 [TBL] [Abstract][Full Text] [Related]
17. [Individual screening for colorectal cancer: which strategy for which patient?]. Demols A; Van Laethem JL; Gay F; Franchimont D; Adler M; Van Gossum A Rev Med Brux; 2001 Sep; 22(4):A203-9. PubMed ID: 11680174 [TBL] [Abstract][Full Text] [Related]
18. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed. Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Leshno M; Niv Y Aliment Pharmacol Ther; 2009 Apr; 29(8):906-17. PubMed ID: 19183147 [TBL] [Abstract][Full Text] [Related]
19. The case for population-based screening for colorectal cancer. Schoen RE Nat Rev Cancer; 2002 Jan; 2(1):65-70. PubMed ID: 11902587 [TBL] [Abstract][Full Text] [Related]
20. The mean number of adenomas per procedure should become the gold standard to measure the neoplasia yield of colonoscopy: a population-based cohort study. Denis B; Sauleau EA; Gendre I; Exbrayat C; Piette C; Dancourt V; Foll Y; Ait Hadad H; Bailly L; Perrin P Dig Liver Dis; 2014 Feb; 46(2):176-81. PubMed ID: 24054769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]